Boston Scientific Strikes Back

$80 a share for Guidant (GDT).
BSX has pushed all its chips to the center of the table. They’re also getting help from Abbott Labs (ABT).
Here’s the press release, and here’s a timeline of the Guidant War from the beginning.

Posted by on January 17th, 2006 at 10:10 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.